Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10694 | 1042 | 34.6 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
527 | 3 | CAFFEINE//COFFEE//GREEN TEA | 20032 |
1588 | 2 | CAFFEINE//ENERGY DRINKS//COFFEE | 7204 |
10694 | 1 | CYP1A2//CAFFEINE//CAFFEINE METABOLISM | 1042 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYP1A2 | authKW | 552009 | 10% | 18% | 103 |
2 | CAFFEINE | authKW | 380562 | 26% | 5% | 268 |
3 | CAFFEINE METABOLISM | authKW | 279224 | 2% | 53% | 18 |
4 | PARAXANTHINE | authKW | 131843 | 1% | 30% | 15 |
5 | 1 METHYLXANTHINE | authKW | 102554 | 1% | 50% | 7 |
6 | CYP1A2 ACTIVITY | authKW | 95895 | 1% | 55% | 6 |
7 | CAFFEINE OXIDATION | authKW | 87909 | 0% | 100% | 3 |
8 | CYP1A2 POLYMORPHISM | authKW | 87909 | 0% | 100% | 3 |
9 | CYTOCHROME P450 1A2 | authKW | 69506 | 1% | 22% | 11 |
10 | 1 METHYLURATE | authKW | 58606 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3686 | 36% | 0% | 371 |
2 | Toxicology | 3563 | 18% | 0% | 187 |
3 | Developmental Biology | 406 | 4% | 0% | 45 |
4 | Obstetrics & Gynecology | 295 | 6% | 0% | 61 |
5 | Nutrition & Dietetics | 276 | 5% | 0% | 51 |
6 | Public, Environmental & Occupational Health | 237 | 7% | 0% | 78 |
7 | Reproductive Biology | 103 | 2% | 0% | 24 |
8 | Pediatrics | 95 | 4% | 0% | 45 |
9 | Veterinary Sciences | 62 | 4% | 0% | 40 |
10 | Food Science & Technology | 60 | 4% | 0% | 41 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PERINATAL NUTR METAB | 43952 | 0% | 50% | 3 |
2 | SECT DEV ENDOCRINOL BIOLYALE CHILD HLTH CT | 39069 | 0% | 67% | 2 |
3 | 4376 KAMIYOGA SETAGAYA KU | 29303 | 0% | 100% | 1 |
4 | ANGARSK AFFILIATED | 29303 | 0% | 100% | 1 |
5 | BIOLFCM | 29303 | 0% | 100% | 1 |
6 | BIRTH DEFECTS PREVENT STUDY | 29303 | 0% | 100% | 1 |
7 | CANC GENET EPIDEMIOL BRANCH | 29303 | 0% | 100% | 1 |
8 | CANC HUMAN CARCINOGENESIS | 29303 | 0% | 100% | 1 |
9 | CHAIRE MED GROSSESSE ALLAITEMENT | 29303 | 0% | 100% | 1 |
10 | CHILD MATERNAL HLTH UNIT | 29303 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOGENETICS | 11157 | 2% | 2% | 19 |
2 | TERATOLOGY | 11015 | 3% | 1% | 27 |
3 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 5436 | 3% | 1% | 33 |
4 | DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS | 5029 | 1% | 2% | 11 |
5 | DRUG METABOLISM AND DISPOSITION | 3471 | 3% | 0% | 30 |
6 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 3209 | 3% | 0% | 30 |
7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2764 | 2% | 0% | 26 |
8 | NEUROBEHAVIORAL TOXICOLOGY AND TERATOLOGY | 2541 | 1% | 1% | 7 |
9 | BIOLOGICAL RESEARCH IN PREGNANCY AND PERINATOLOGY | 1878 | 0% | 2% | 3 |
10 | FOOD AND CHEMICAL TOXICOLOGY | 1800 | 2% | 0% | 23 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYP1A2 | 552009 | 10% | 18% | 103 | Search CYP1A2 | Search CYP1A2 |
2 | CAFFEINE | 380562 | 26% | 5% | 268 | Search CAFFEINE | Search CAFFEINE |
3 | CAFFEINE METABOLISM | 279224 | 2% | 53% | 18 | Search CAFFEINE+METABOLISM | Search CAFFEINE+METABOLISM |
4 | PARAXANTHINE | 131843 | 1% | 30% | 15 | Search PARAXANTHINE | Search PARAXANTHINE |
5 | 1 METHYLXANTHINE | 102554 | 1% | 50% | 7 | Search 1+METHYLXANTHINE | Search 1+METHYLXANTHINE |
6 | CYP1A2 ACTIVITY | 95895 | 1% | 55% | 6 | Search CYP1A2+ACTIVITY | Search CYP1A2+ACTIVITY |
7 | CAFFEINE OXIDATION | 87909 | 0% | 100% | 3 | Search CAFFEINE+OXIDATION | Search CAFFEINE+OXIDATION |
8 | CYP1A2 POLYMORPHISM | 87909 | 0% | 100% | 3 | Search CYP1A2+POLYMORPHISM | Search CYP1A2+POLYMORPHISM |
9 | CYTOCHROME P450 1A2 | 69506 | 1% | 22% | 11 | Search CYTOCHROME+P450+1A2 | Search CYTOCHROME+P450+1A2 |
10 | 1 METHYLURATE | 58606 | 0% | 100% | 2 | Search 1+METHYLURATE | Search 1+METHYLURATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NEHLIG, A , DERBY, G , (1994) POTENTIAL TERATOGENIC AND NEURODEVELOPMENTAL CONSEQUENCES OF COFFEE AND CAFFEINE EXPOSURE - A REVIEW ON HUMAN AND ANIMAL DATA.NEUROTOXICOLOGY AND TERATOLOGY. VOL. 16. ISSUE 6. P. 531-543 | 117 | 79% | 66 |
2 | BRENT, RL , CHRISTIAN, MS , DIENER, RM , (2011) EVALUATION OF THE REPRODUCTIVE AND DEVELOPMENTAL RISKS OF CAFFEINE.BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY. VOL. 92. ISSUE 2. P. 152 -187 | 83 | 52% | 41 |
3 | PERERA, V , GROSS, AS , MCLACHLAN, AJ , (2012) MEASUREMENT OF CYP1A2 ACTIVITY: A FOCUS ON CAFFEINE AS A PROBE.CURRENT DRUG METABOLISM. VOL. 13. ISSUE 5. P. 667 -678 | 70 | 58% | 19 |
4 | CHRISTIAN, MS , BRENT, RL , (2001) TERATOGEN UPDATE: EVALUATION OF THE REPRODUCTIVE AND DEVELOPMENTAL RISKS OF CAFFEINE.TERATOLOGY. VOL. 64. ISSUE 1. P. 51 -78 | 77 | 71% | 61 |
5 | GROSSO, LM , BRACKEN, MB , (2005) CAFFEINE METABOLISM, GENETICS, AND PERINATAL OUTCOMES: A REVIEW OF EXPOSURE ASSESSMENT CONSIDERATIONS DURING PREGNANCY.ANNALS OF EPIDEMIOLOGY. VOL. 15. ISSUE 6. P. 460-466 | 55 | 77% | 55 |
6 | NEHLIG, A , DEBRY, G , (1994) CONSEQUENCES ON THE NEWBORN OF CHRONIC MATERNAL CONSUMPTION OF COFFEE DURING GESTATION AND LACTATION - A REVIEW.JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION. VOL. 13. ISSUE 1. P. 6-21 | 92 | 69% | 34 |
7 | PERERA, V , GROSS, AS , POLASEK, TM , QIN, Y , RAO, G , FORREST, A , XU, JZ , MCLACHLAN, AJ , (2013) CONSIDERING CYP1A2 PHENOTYPE AND GENOTYPE FOR OPTIMIZING THE DOSE OF OLANZAPINE IN THE MANAGEMENT OF SCHIZOPHRENIA.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 9. ISSUE 9. P. 1115 -1137 | 68 | 38% | 5 |
8 | HAKOOZ, NMK , (2009) CAFFEINE METABOLIC RATIOS FOR THE IN VIVO EVALUATION OF CYP1A2, N-ACETYLTRANSFERASE 2, XANTHINE OXIDASE AND CYP2A6 ENZYMATIC ACTIVITIES.CURRENT DRUG METABOLISM. VOL. 10. ISSUE 4. P. 329-338 | 45 | 59% | 14 |
9 | RHEE, J , KIM, R , KIM, Y , TAM, M , LAI, YZ , KEUM, N , OLDENBURG, CE , (2015) MATERNAL CAFFEINE CONSUMPTION DURING PREGNANCY AND RISK OF LOW BIRTH WEIGHT: A DOSE-RESPONSE META-ANALYSIS OF OBSERVATIONAL STUDIES.PLOS ONE. VOL. 10. ISSUE 7. P. - | 29 | 69% | 3 |
10 | BOYLAN, S , CADE, JE , DOLBY, VA , GREENWOOD, DC , HAY, AWM , KIRK, SFL , SHIRES, S , SIMPSON, N , THOMAS, JD , WALKER, J , ET AL (2008) MATERNAL CAFFEINE INTAKE DURING PREGNANCY AND RISK OF FETAL GROWTH RESTRICTION: A LARGE PROSPECTIVE OBSERVATIONAL STUDY.BRITISH MEDICAL JOURNAL. VOL. 337. ISSUE . P. - | 27 | 90% | 9 |
Classes with closest relation at Level 1 |